Home » Newsletters » BioWorld

BioWorld

Aug. 22, 1991

View Archived Issues

VHA TO TEST BIOJECT DRUG DELIVERY SYSTEM

SYNERGEN LEASES PHARMACEUTICAL PLANT

WARNER-LAMBERT TO SELL KABI'S NICOTINE PATCH

CYTRX GETS ANOTHER RHEOTHRX PATENT

TECHNE TO SELL CHEMICAL INSTRUMENT SUBSIDIARY

GATEWAY FOR AIDS TO NERVOUS SYSTEM

VIAGENE COMPLETES PRIVATE PLACEMENT

ONCOGENE FILES 3.2 MILLION-SHARE OFFERING

ATHENA TO COLLABORATE WITH WYETH-AYERST

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...